35
Views
0
CrossRef citations to date
0
Altmetric
LETTER

Serum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast Cancer Patients [Letter]

ORCID Icon, &
Pages 221-222 | Received 07 Apr 2024, Accepted 10 Apr 2024, Published online: 10 Apr 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.